These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15249736)

  • 1. Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol.
    D'Astous M; Gajjar TM; Dluzen DE; Di Paolo T
    Neuroendocrinology; 2004; 79(6):296-304. PubMed ID: 15249736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential protective properties of estradiol and tamoxifen against methamphetamine-induced nigrostriatal dopaminergic toxicity in mice.
    D'Astous M; Mickley KR; Dluzen DE; Di Paolo T
    Neuroendocrinology; 2005; 82(2):111-20. PubMed ID: 16446547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
    Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system of ovariectomized mice.
    Liu B; Dluzen DE
    Neuroendocrinology; 2006; 83(5-6):295-302. PubMed ID: 16926530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice.
    Callier S; Morissette M; Grandbois M; Pélaprat D; Di Paolo T
    Synapse; 2001 Aug; 41(2):131-8. PubMed ID: 11400179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
    Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system.
    Liu B; Dluzen DE
    Synapse; 2006 Oct; 60(5):354-61. PubMed ID: 16838362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system.
    Gajjar TM; Anderson LI; Dluzen DE
    J Neural Transm (Vienna); 2003 Nov; 110(11):1215-24. PubMed ID: 14628187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response effects of estrogen and tamoxifen upon methamphetamine-induced behavioral responses and neurotoxicity of the nigrostriatal dopaminergic system in female mice.
    Mickley KR; Dluzen DE
    Neuroendocrinology; 2004; 79(6):305-16. PubMed ID: 15256808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of striatal preproenkephalin mRNA levels in MPTP-lesioned mice treated with estradiol.
    D'Astous M; Morissette M; Callier S; Di Paolo T
    J Neurosci Res; 2005 Apr; 80(1):138-44. PubMed ID: 15723346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
    Calon F; Lavertu N; Lemieux AM; Morissette M; Goulet M; Grondin R; Blanchet PJ; Bédard PJ; Di Paolo T
    Synapse; 2001 Jun; 40(3):225-34. PubMed ID: 11304760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM
    J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
    Jourdain S; Morissette M; Morin N; Di Paolo T
    J Neuroendocrinol; 2005 Aug; 17(8):509-17. PubMed ID: 16011487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.
    Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL
    Neurotoxicology; 2004 Sep; 25(5):761-9. PubMed ID: 15288507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations.
    Joyce JN; Renish L; Osredkar T; Walro JM; Kucera J; Dluzen DE
    Synapse; 2004 Apr; 52(1):11-9. PubMed ID: 14755628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of testosterone and dihydrotestosterone compared to 17beta-oestradiol in 1-methyl-4-phenyl-1,2,3,6, tetrahydropyridine-mice.
    Ekue A; Boulanger JF; Morissette M; Di Paolo T
    J Neuroendocrinol; 2002 Sep; 14(9):731-6. PubMed ID: 12213134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced dopamine uptake in the striatum following repeated restraint stress.
    Copeland BJ; Neff NH; Hadjiconstantinou M
    Synapse; 2005 Sep; 57(3):167-74. PubMed ID: 15945060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine.
    Sotnikova TD; Budygin EA; Jones SR; Dykstra LA; Caron MG; Gainetdinov RR
    J Neurochem; 2004 Oct; 91(2):362-73. PubMed ID: 15447669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of neonatal and prepubertal hormonal manipulations upon estrogen neuroprotection of the nigrostriatal dopaminergic system within female and male mice.
    Anderson LI; Leipheimer RE; Dluzen DE
    Neuroscience; 2005; 130(2):369-82. PubMed ID: 15664693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease.
    Al-Sweidi S; Morissette M; Bourque M; Di Paolo T
    Neuropharmacology; 2011 Sep; 61(4):583-91. PubMed ID: 21586296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.